Search

Your search keyword '"Scott, Janet"' showing total 1,088 results

Search Constraints

Start Over You searched for: Author "Scott, Janet" Remove constraint Author: "Scott, Janet"
1,088 results on '"Scott, Janet"'

Search Results

101. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

102. The AFFIRM study: Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial: LB02

106. Do we need consent to obtain consent? Public and participant feedback to using personal health data for recruitment

107. Long-COVID in Scotland Study: a nationwide, population cohort study

108. Pandemic, Epidemic, Endemic: B Cell Repertoire Analysis Reveals Unique Anti-Viral Responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus

111. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

112. Covid-19: virology, variants, and vaccines

113. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study

114. Additional file 1 of Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID)

115. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

116. Severe efavirenz associated neurotoxicity: A retrospective cohort study.

118. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

120. Prevalence and Risk Factors of Post-COVID-19 Condition in Adults and Children at 6 and 12 Months After Hospital Discharge: A Prospective, Cohort Study in Moscow (Stop COVID)

124. Recovery from Covid-19 critical illness: a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial

125. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

126. COVID-19 symptoms at hospital admission vary with age and sex

128. The value of open-source clinical science in pandemic response: lessons from ISARIC

130. Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19

131. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol

138. Recovery from Covid-19 critical illness:a secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial

139. What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review

140. Pandemic, epidemic, endemic: B cell repertoire analysis reveals unique anti-viral responses to SARS-CoV-2, Ebola and Respiratory Syncytial Virus

141. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

142. Conservation actions benefit the most threatened species: A 13‐year assessment of Alliance for Zero Extinction species

144. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

145. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

146. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

147. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

148. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

150. sj-pdf-1-inc-10.1177_17511437211052226 – Supplemental Material for Recovery from Covid-19 critical illness: A secondary analysis of the ISARIC4C CCP-UK cohort study and the RECOVER trial

Catalog

Books, media, physical & digital resources